Companion diagnostics for precision medicine

23 March 2023 09:30-17:00, London, United Kingdom

Companion diagnostics are becoming more and more important with time together with the growth of targeted therapies. Precision medicine approach aims to stratify patients with the ultimate aim of targeting patients who are most likely to respond to a specific treatment. Currently, CDx are used for many diseases lung cancer, colorectal cancer, breast cancer and melanoma.

At the Royal Society of Chemistry, delegates will be able to explore the current state of the art in vitro diagnostic tests used by the industry and explore the different scientific measurements that are needed to develop and deliver a CDx into the market.

CDx is a platform technology and can be used for many other diseases, join us and lets discuss the future of healthcare and personalised treatment.
The Royal Society of Chemistry

The Royal Society of Chemistry, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry